Avita signals revenue recovery with $70M-$74M 2025 outlook following reimbursement clarity
Source: SeekingAlpha
2025-11-06 20:06:51 ET
More on AVITA Medical
- AVITA Medical, Inc. (RCEL) Q3 2025 Earnings Call Transcript
- AVITA Medical: Reimbursement Reset And Breakeven Path By 2026
- AVITA Medical, Inc. (RCEL) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)
- AVITA Medical Q3 2025 Earnings Preview
- AVITA Medical appoints Cary Vance as interim CEO
Read the full article on Seeking Alpha
For further details see:
Avita signals revenue recovery with $70M–$74M 2025 outlook following reimbursement clarity
Avita Medical Inc.
NASDAQ: RCEL
RCEL Trading
-3.91% G/L:
$4.42 Last:
63,395 Volume:
$4.61 Open:
RCEL Latest News
February 23, 2026 04:15:00 pm
AVITA Medical to participate at the TD Cowen 46th Annual Health Care Conference
February 12, 2026 04:01:00 pm
AVITA Medical Reports Fourth Quarter and Full Year 2025 Financial Results
RCEL Stock Data
$122,429,841
29,639,304
0.44%
22
N/A
Medical Equipment & Supplies
Healthcare
US
Valencia
